<code id='175AB7DBCA'></code><style id='175AB7DBCA'></style>
    • <acronym id='175AB7DBCA'></acronym>
      <center id='175AB7DBCA'><center id='175AB7DBCA'><tfoot id='175AB7DBCA'></tfoot></center><abbr id='175AB7DBCA'><dir id='175AB7DBCA'><tfoot id='175AB7DBCA'></tfoot><noframes id='175AB7DBCA'>

    • <optgroup id='175AB7DBCA'><strike id='175AB7DBCA'><sup id='175AB7DBCA'></sup></strike><code id='175AB7DBCA'></code></optgroup>
        1. <b id='175AB7DBCA'><label id='175AB7DBCA'><select id='175AB7DBCA'><dt id='175AB7DBCA'><span id='175AB7DBCA'></span></dt></select></label></b><u id='175AB7DBCA'></u>
          <i id='175AB7DBCA'><strike id='175AB7DBCA'><tt id='175AB7DBCA'><pre id='175AB7DBCA'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:entertainment    Page View:8694
          Adobe

          Private Medicare just isn’t the gold mine it once was. Case in point: Cano Health, a company once valued at $4.4 billion, is now bankrupt.

          The prospect of bankruptcy had stalked the Miami-based primary care provider for well over a year before its Chapter 11 filing on Sunday. A number of things had gone wrong. First, there was Cano’s rapid growth ahead of its 2021 initial public offering that gave way to a mountain of debt, currently sitting at $1.3 billion. Then there was public beef between its former directors and then-CEO.

          advertisement

          Most importantly, the company’s main business, Medicare Advantage, became less profitable. As evidence accumulated that the private insurers running MA plans game the system by exaggerating their members’ illnesses, the Biden administration vowed to fix the problem. This year, Medicare is phasing in a new payment model designed to reduce overpayment.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee
          Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          JPM 2024: Nvidia claims we're in biological revolution. Are we?

          SipaviaAPImagesSANFRANCISCO—Thesmallhotelmeetingroomwaspackedlikearushhoursubway.Bankersindarksuitsw